An All-Bioactive Glycyrrhizic Acid–Ginsenoside Rb1 Supramolecular Hydrogel Improves Diabetic Perforator Flap Survival and Is Associated with Immune–Vascular Remodeling
Background: Distal necrosis of multi-territory perforator flaps remains a major challenge in diabetic reconstruction, driven primarily by blunted angiogenesis, persistent inflammation and defective vascular remodeling within the Choke zone. Bioactive supramolecular hydrogels that locally coordinate immune and vascular repair represent a promising strategy to improve flap viability under diabetic conditions. Methods: A crosslinker-free supramolecular hydrogel, GRb1@GA-gel, was engineered via spontaneous co-assembly of glycyrrhizic acid ammonium salt and ginsenoside Rb1, and its gelation kinetics, injectability, shear-thinning properties, and nanofibrous architecture were characterized. The effects of GRb1@GA-gel on endothelial angiogenic activity and macrophage polarization were evaluated in vitro. A murine diabetic multi-territory perforator flap model was established to quantify flap survival, microvessel formation, collagen deposition, and Choke-zone remodeling following local hydrogel delivery. Network pharmacology, molecular docking, RNA sequencing, and molecular analyses were integrated to dissect underlying regulatory pathways, with a focus on STAT-related signaling. Results: GRb1@GA-gel self-assembled into a stable, injectable nanofibrous hydrogel without requiring exogenous chemical crosslinkers. In vitro, the hydrogel enhanced angiogenic endothelial responses and upregulated the expression of VEGF, HIF-1α, and eNOS. It also skewed macrophage polarization toward an M2-like reparative phenotype, as evidenced by increased IL-10 and Arg-1 alongside reduced TNF-α and IL-1β. In diabetic perforator flaps, local GRb1@GA-gel treatment markedly improved flap survival, increased microvessel density, and fostered better-organized collagen deposition within the Choke zone. Transcriptomic and molecular analyses further indicated that these improvements were accompanied by transcriptional and molecular changes consistent with angiogenic remodeling, inflammatory microenvironment reprogramming, and altered STAT1/STAT3-related signaling, although the causal roles of these pathways remain unestablished. Conclusions: GRb1@GA-gel represents an all-bioactive, self-assembled supramolecular hydrogel that unifies scaffold formation, localized therapeutic cargo delivery, immunomodulation, and angiogenic remodeling. Associated with remodeling of the immune–vascular microenvironment within the diabetic Choke zone, this hydrogel improves perforator flap survival and offers a potentially translatable strategy for ischemic tissue repair in diabetes.